FDA product code HGH: Cannula, Suction, Uterine

HGH is the FDA product code for cannula, suction, uterine. It is a Class II device, regulated under 21 CFR 884.5070 and reviewed by the Obstetrics and Gynecology panel. FDA has cleared 6 510(k) submissions under HGH, from 6 different applicants. The average 510(k) review took 234 days (median 247).

Classification

FieldValue
Device nameCannula, Suction, Uterine
Device classClass II
Regulation21 CFR 884.5070
Review panelOB — Obstetrics and Gynecology
Medical specialtyObstetrics/Gynecology
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for HGH

YearClearancesAvg. review days
20171269
20181266

Compare with all 510(k) review times · Search every HGH clearance

Top HGH applicants

ApplicantClearancesLatest
Chongquin Jinshan Science & Technology (Group) Co., Ltd.12018-04-09
Panpac Medical Corporation12017-01-13
Dongguan Microview Medical Technology Co., Ltd.12015-03-25
Womancare Global12010-03-04
Kolster Methods11994-07-19

1 more applicants have HGH clearances. See the full list in Caduvo.

Most recent HGH clearances

510(k)ApplicantDeviceDecision dateReview days
K172151Chongquin Jinshan Science & Technology (Group) Co., Ltd.Hysteroscopy System2018-04-09266
K161106Panpac Medical CorporationPANPAC DISPOSABLE VACUUM CURETTES2017-01-13269
K140213Dongguan Microview Medical Technology Co., Ltd.DISPOSABLE ENDOSCOPIC CANNULA2015-03-25421
K093508Womancare GlobalRIGID CANNULAE CURVED (RC6-RC12), RIGID CANNULAE STRAIGHT (RS6-RS12)2010-03-04112
K935820Kolster MethodsKOLSTER METHODS1994-07-19228

Recalls for HGH devices

openFDA lists no recalls for product code HGH.

Frequently asked questions

What is FDA product code HGH?

HGH is the FDA product code for cannula, suction, uterine. It is a Class II device, regulated under 21 CFR 884.5070 and reviewed by the Obstetrics and Gynecology panel.

What device class is HGH?

Class II, regulation 21 CFR 884.5070. Typical premarket route: 510(k).

How long does a 510(k) take for product code HGH?

Across 6 cleared submissions the average was 234 days from receipt to decision (median 247).

Which companies have the most HGH clearances?

Chongquin Jinshan Science & Technology (Group) Co., Ltd. (1); Panpac Medical Corporation (1); Dongguan Microview Medical Technology Co., Ltd. (1); Womancare Global (1); Kolster Methods (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Obstetrics and Gynecology product codes · FDA product code lookup · 510(k) database search · 510(k) review times